title: Extensive posttreatment ganglioneuromatous differentiation of rhabdomyosarcoma: malignant ectomesenchymoma in an infant.
authors.forename: Neil J
authors.initials: NJ
authors.lastname: Sebire
authors.forename: Alan D
authors.initials: AD
authors.lastname: Ramsay
authors.forename: Marion
authors.initials: M
authors.lastname: Malone
authors.forename: R Anthony
authors.initials: RA
authors.lastname: Risdon
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis; D003893:Desmin / Q000032:analysis; D005729:Ganglioneuroma / Q000737:chemistry / Q000188:drug therapy / Q000473:pathology*; D006801:Humans; D007150:Immunohistochemistry; D007223:Infant; D008048:Lip Neoplasms / Q000737:chemistry / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D008637:Mesenchymoma / Q000737:chemistry / Q000188:drug therapy / Q000473:pathology*; D017570:MyoD Protein / Q000032:analysis; D018008:Myogenin / Q000032:analysis; D016609:Neoplasms, Second Primary / Q000473:pathology*; D012208:Rhabdomyosarcoma / Q000737:chemistry / Q000188:drug therapy / Q000473:pathology*; D012983:Soft Tissue Neoplasms / Q000737:chemistry / Q000188:drug therapy / Q000473:pathology*
chemical_list: D014408:Biomarkers, Tumor; D003893:Desmin; C503799:MYOG protein, human; D017570:MyoD Protein; C057363:MyoD1 myogenic differentiation protein; D018008:Myogenin